Related Experiment Video
Updated: Oct 20, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
"Please see this man with a 69-year history of hypoglycaemia"
Robert M Gifford1, Evgenia Foteinopoulou2, Mark W J Strachan3
1Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, UK; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK; Royal Centre of Defence Medicine, Birmingham, UK.
Abstract:
Mutations in the HNF4A gene are associated with hyperinsulinaemic hypoglycaemia in infants, frequently evolving into relative deficiency of insulin in adulthood ---as maturity onset diabetes of the young (MODY). A 69-year-old male with a strong family history of adult-onset diabetes was referred with lifelong hypoglycaemia, found to be due to a pathogenic HNF4A mutation. HbA1c levels were low, continuous glucose monitoring demonstrated frequent low glucose events in the early morning, and he was successfully treated with diazoxide. This case represents a new phenotype of a known mutation associated more commonly with MODY. The same mutation in one family led to profoundly different manifestations. Genetic causes of hyperinsulinaemic hypoglycaemia can present late in life and identifying such cases is important to allow the correct treatment to be established.
Insights
A rare HNF4A gene mutation caused lifelong hypoglycemia in a 69-year-old man, a new presentation for this condition. This highlights that genetic causes of low blood sugar can manifest late in life.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Disorders
Background:
- Mutations in the Hepatocyte Nuclear Factor 4 Alpha (HNF4A) gene are typically linked to hyperinsulinaemic hypoglycemia in infants.
- These mutations often lead to maturity-onset diabetes of the young (MODY) later in life.
- Genetic causes of hyperinsulinaemic hypoglycemia can exhibit variable clinical presentations.
Observation:
- A 69-year-old male with a family history of adult-onset diabetes presented with lifelong hypoglycemia.
- He was found to have a pathogenic HNF4A mutation.
- Continuous glucose monitoring revealed frequent early morning hypoglycemia, and low HbA1c levels were noted.
Findings:
- The patient's lifelong hypoglycemia was attributed to a pathogenic HNF4A mutation, a novel phenotype for this genetic alteration.
- The same HNF4A mutation presented with distinct clinical manifestations within the same family.
- Successful treatment was achieved using diazoxide, an established therapy for hyperinsulinaemic hypoglycemia.
Implications:
- Genetic causes of hyperinsulinaemic hypoglycemia can present with late-onset symptoms, challenging typical diagnostic patterns.
- Identifying these late-onset cases is crucial for establishing appropriate and effective treatment strategies.
- This case broadens the understanding of HNF4A mutation phenotypes and their variable expressivity.
More Related Videos
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...